ICAP

Welcome to ANApatterns.org, the official website for the International Consensus on Antinuclear Antibody (ANA) Patterns (ICAP). ICAP was initiated as a workshop aiming to thoroughly discuss and to promote consensus regarding the richness and nuances of morphological patterns observed in the indirect immunofluorescence assay on HEp-2 cells (HEp-2 IFA). The ICAP initiative was implemented at the 12th International Workshop on Autoantibodies and Autoimmunity (IWAA, São Paulo, Brazil) by members of the Autoantibody Standardization Committee (ASC), a subcommittee of the International Union of Immunological Societies (IUIS) Quality Assessment and Standardization Committee and affiliated with the Centers for Diseases Control and Prevention (CDC). The ICAP committee is operating as an ASC sub-committee.

Illustrative images were submitted for each pattern and ICAP members voted and selected the most representative ones paying attention to pixel dimension, resolution, and size. The highest ranked images for each pattern are displayed on this web site. (For an introduction of the website with some graphic images, click here.)

The ICAP committee acknowledges that the term ANA is outdated as discussed in several publications [1, 2] and yet ANA is still most commonly used in the current literature. We have proposed to use the term HEp-2 IFA to precisely describe the test in practice and used in most ICAP publications [3, 4]. Anti-Cell (AC) is used in ICAP coding of HEp-2 IFA patterns [3, 4]. Although the term anti-cellular antibody has been used in place of ANA by ICAP [2] and others [1], there is support for and reservations about its accuracy because the term “anti-cellular" also encompasses a wide spectrum of autoantibodies detected by other assays – e.g. ANCA, ASMA, APCA.

  1. Agmon-Levin, N., et al., International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis, 2014. 73(1): p. 17-23.
  2. von Muhlen, C.A., et al., How to report the antinuclear antibodies (anti-cell antibodies) test on HEp-2 cells: guidelines from the ICAP initiative. Immunol Res, 2021. 69(6): p. 594-608.
  3. Damoiseaux, J., et al., Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective. Ann Rheum Dis, 2019. 78(7): p. 879-889.
  4. Chan, E.K.L., et al., Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014-2015. Front Immunol, 2015. 6: p. 412.


 
Announcements and Updates
Fri, 10 Jun 22

The complete translation draft to Ukrainian goes online.

Tue, 01 Feb 22

The complete translation draft to Japanese goes online.

Mon, 10 Jan 22

NEW PUBLICATION:
"The International Consensus on ANA Patterns (ICAP) in 2021—The 6th Workshop and Current Perspectives”

https://academic.oup.com/jalm/article/7/1/322/6498242?guestAccessKey=c7ece6c7-ecd2-42a4-ab14-bb35d97...

View all announcements


 
HEp-2 CIC Project

Despite the worldwide acceptance of ICAP recommendations by clinical laboratories, academic institutions and vitro diagnostic industries, there is still considerable heterogeneity regarding the iterpretation and reporting of HEp-2 among different laboratories. Click here

 
FAQ - Frequently Asked Questions

Submit your question to ICAP. Only confirmed users can submit a question. If you are not registered, click here to start. Submitted questions will be routed to ICAP Coordinators Edward K. L. Chan (echan@ufl.edu) and Luis E. C. Andrade (luis.andrade@unifesp.br). Simple questions will be answered within 24 hours. Complex questions will be routed to several ICAP members either for a consensus or to provide different viewpoints and it may take 72 hours to 2 weeks for an answer. click here

 
 
Online since 19 May 2015